Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: ?
Life Threatening? No
Write-up: Shoulder pain; Drooling; Pain in arm; Sweating; Nausea; Patient collapsed on way to taxi and died; This is a spontaneous case reported by pharmacist to Regulatory Authority [regulatory reference number: GB-MHRA-EYC 00209913] and initially retrieved on 25-Oct-2019, concerning a female patient of unreported age. The patient''s medical history and concomitant medications were not provided. On 05-Oct-2019, the patient was administered Fluad TIV [influenza vaccine, inactivated influenza virus surface antigen, egg-derived, MF59; dose: 0.5 ml, route of administration: intramuscular, anatomical location: arm, batch number and expiration date: not reported] for influenza immunisation. On an unspecified date in Oct-2019, unknown amount of time after vaccination, the patient experienced nausea, sweating, drooling, pain in arm and shoulder. On 09-Oct-2019, reported as five days after vaccination, the patient contacted Health Service and was advised by a doctor to came to see them. On the way to taxi, the patient collapsed and died. It was unknown if the autopsy was performed. At the time of death, the events of ''nausea'', ''sweating'', ''drooling'', ''shoulder pain'' and ''pain in arm'' were still ongoing. The case was assessed as serious. The reporter did not provide causality assessment. Company Comment: The events of ''circulatory collapse'', ''nausea'', ''sweating'', ''drooling'', ''shoulder pain'' and ''pain in arm'' are considered related to Fluad TIV.; Sender''s Comments: The events of ''circulatory collapse'', ''nausea'', ''sweating'', ''drooling'', ''shoulder pain'' and ''pain in arm'' are considered related to Fluad TIV.; Reported Cause(s) of Death: Circulatory collapse
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166